Financial News

Financial Report: AbbVie

Humira sales top $16 billion for the year

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AbbVie   4Q Revenues: $6.8 billion (+6%) 4Q Earnings: $1.4 billion (-8%) FY Revenues: $25.6 billion (+12%) FY Earnings: $6.0 billion (+16%) Comments: Humira sales were $16.1 billion for the year, up 15%. Imbruvica sales reached $1.8 billion for the year. Viekira sales were down 7% to $1.5 billion as a result of increased competition in the Hep C market. Lupron sales were pretty much flat at $821 million. Synagis sales were $730 million, down 2%. Synthroid sales were up 1% to $763 m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters